You are here: All Products  > Simcere Reports Anti-Neutropenia Oncology Drug Meets Phase III Endpoint

Simcere Reports Anti-Neutropenia Oncology Drug Meets Phase III Endpoint

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products